How Analysts Feel About Humana Inc. (HUM) After Making 52-Week High?

April 17, 2018 - By Clifton Ray

Humana Inc. (NYSE:HUM) Logo

Investors sentiment decreased to 1.05 in 2017 Q4. Its down 0.16, from 1.21 in 2017Q3. It fall, as 40 investors sold Humana Inc. shares while 209 reduced holdings. 69 funds opened positions while 193 raised stakes. 125.53 million shares or 4.46% less from 131.39 million shares in 2017Q3 were reported.
Maverick Ltd owns 36,410 shares. 41 were accumulated by Advisory Service Net Ltd Liability Company. Tiaa Cref Inv Management Ltd Liability accumulated 1.30M shares or 0.21% of the stock. Daiwa Securities Group Inc, Japan-based fund reported 4,392 shares. Brandywine Mgmt Ltd Liability Com has invested 0.04% in Humana Inc. (NYSE:HUM). Argent has 0.14% invested in Humana Inc. (NYSE:HUM) for 2,159 shares. Riverhead Capital Mgmt Limited Company owns 63,441 shares. 231,209 were accumulated by Asset Mgmt One Ltd. Partner Mgmt Limited Partnership reported 1.79% of its portfolio in Humana Inc. (NYSE:HUM). Cambridge Inv Rech Advsrs has invested 0.01% in Humana Inc. (NYSE:HUM). B And T Mgmt Dba Alpha Mgmt holds 1.05% or 8,954 shares in its portfolio. Jennison Associate Llc holds 0.1% or 411,225 shares. Shell Asset has 0.05% invested in Humana Inc. (NYSE:HUM) for 10,869 shares. Barr E S holds 3,850 shares or 0.1% of its portfolio. Metropolitan Life New York invested in 28,295 shares.

Since December 15, 2017, it had 0 buys, and 10 sales for $20.82 million activity. On Friday, December 15 BILNEY JODY L sold $1.75 million worth of Humana Inc. (NYSE:HUM) or 7,054 shares. BROUSSARD BRUCE D had sold 14,075 shares worth $3.86 million on Saturday, February 24. 16,389 shares valued at $4.48 million were sold by Christopher M Todoroff on Saturday, February 24. Shares for $340,034 were sold by Huval Timothy S. on Friday, December 15. $295,450 worth of Humana Inc. (NYSE:HUM) shares were sold by Fleming William Kevin. MARGULIS HEIDI S sold $1.03M worth of stock or 3,727 shares.

The stock of Humana Inc. (NYSE:HUM) hit a new 52-week high and has $314.50 target or 6.00 % above today’s $296.70 share price. The 8 months bullish chart indicates low risk for the $40.97 billion company. The 1-year high was reported on Apr, 17 by Barchart.com. If the $314.50 price target is reached, the company will be worth $2.46B more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock increased 2.33% or $6.75 during the last trading session, reaching $296.7. About 313,010 shares traded. Humana Inc. (NYSE:HUM) has risen 31.54% since April 17, 2017 and is uptrending. It has outperformed by 19.99% the S&P500.

Analysts await Humana Inc. (NYSE:HUM) to report earnings on May, 2. They expect $3.21 earnings per share, up 16.73 % or $0.46 from last year’s $2.75 per share. HUM’s profit will be $443.25M for 23.11 P/E if the $3.21 EPS becomes a reality. After $2.06 actual earnings per share reported by Humana Inc. for the previous quarter, Wall Street now forecasts 55.83 % EPS growth.

Humana Inc. (NYSE:HUM) Ratings Coverage

Among 13 analysts covering Humana Inc (NYSE:HUM), 9 have Buy rating, 0 Sell and 4 Hold. Therefore 69% are positive. Humana Inc had 24 analyst reports since October 23, 2017 according to SRatingsIntel. The company was maintained on Wednesday, February 7 by Cantor Fitzgerald. On Thursday, February 8 the stock rating was upgraded by Credit Suisse to “Outperform”. The firm earned “Buy” rating on Monday, November 27 by Leerink Swann. The company was maintained on Tuesday, April 3 by Piper Jaffray. The rating was initiated by Credit Suisse on Friday, November 3 with “Hold”. The stock of Humana Inc. (NYSE:HUM) has “Neutral” rating given on Monday, February 12 by JP Morgan. BMO Capital Markets maintained the stock with “Outperform” rating in Friday, November 10 report. The firm earned “Buy” rating on Thursday, April 12 by Jefferies. The stock of Humana Inc. (NYSE:HUM) earned “Buy” rating by Leerink Swann on Thursday, February 8. Morgan Stanley maintained Humana Inc. (NYSE:HUM) rating on Thursday, November 9. Morgan Stanley has “Overweight” rating and $270 target.

Humana Inc., together with its subsidiaries, operates as a health and well-being firm in the United States. The company has market cap of $40.97 billion. The firm operates through three divisions: Retail, Group, and Healthcare Services. It has a 17.65 P/E ratio. The Retail segment offers Medicare benefits, as well as commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products directly to individuals or through group accounts.

Humana Inc. (NYSE:HUM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.